| | | | | |
ANIK Anika Therapeutics Inc | $21,6400 | +0,79% | $294,82M | $86,92K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4600 | -0,66% | $294,73M | $400,00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0400 | +0,00% | $294,68M | $5,02K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $43,0000 | +0,56% | $294,53M | $30,86K | |
| $45,1150 | +0,41% | $294,35M | $16,68K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0190 | +0,19% | $294,35M | $100,01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0700 | -0,10% | $294,33M | $190,00 | |
SLN Silence Therapeutics Plc American Depository Share | $14,0800 | -1,88% | $294,27M | $1,48M | |
MTNE CH4 Natural Solutions Corporation | $9,8750 | +0,04% | $293,88M | $144,00 | |
RXST RxSight, Inc. Common Stock | $6,3700 | -1,70% | $293,64M | $712,53K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6400 | +0,00% | $293,52M | $115,83K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0050 | -0,10% | $293,49M | $86,50K | |
CNXU Conexeu Sciences Inc. Common Stock | $10,0000 | +2,25% | $293,27M | $403,02K | |
| $9,9646 | -2,97% | $292,98M | $1,19M | |
JCE Nuveen Core Equity Alpha Fund | $17,0800 | -0,76% | $292,78M | $23,09K | |
